Thursday, 19 December 2019

Ophthalmic Drugs Market: Segmented By Application And Geography Trends, Growth And Forecasts To 2023


KD Market Insights has published a new report titled “Ophthalmic Drugs Market – by Indication (Dry Eye, Glaucoma, Infection/Inflammation/Allergy, Retinal Disorders, and Others), Type (Prescription Drugs, and Over-the-Counter Drugs), Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, and Other Ophthalmic Drug Forms), Technology (Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small Molecule, and Others), Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, and Others), and Therapeutic Class (Anti-glaucoma, Anti-infection, Anti-inflammatory, and Anti-allergy) - Global Opportunity Analysis and Industry Forecast, 2017-2023,”.

According to report, the global Ophthalmic Drugs market was valued at around USD $29,613 Million in 2016 and is expected to reach approximately USD $42,663 Million by 2023, growing at a CAGR of around 5.3% between 2017 and 2023.


The market research report provides a thorough analysis of the industry trends, market opportunities, growth drivers which would help the investors to create and align their market strategies according to the current and future market dynamics.

The study is segmented based on By Indication, By Type, By Dosage Form, By Technology, By Distribution Channel, By Therapeutic Class, and geographical regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Further, the report also analyses key countries such as United States, China, Japan, Germany, United Kingdom, Korea, Brazil, GCC, Africa and Southeast Asia & India.

The report is sub-segmented By Indication – Dry Eye, Glaucoma, Infection/Inflammation/Allergy, Retinal Disorders – (Wet Age-related Macular Degeneration, Dry Age-related Macular Degeneration, Diabetic Retinopathy, Others), Others. By Type – Prescription Drugs, Over-the-Counter Drugs. By Dosage Form – Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Other Ophthalmic Drug Forms. By Technology – Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small Molecule, Others. By Distribution Channel – Hospital Pharmacies, Drug Stores, Online Pharmacies, Others. By Therapeutic Class -Anti-glaucoma. Anti-infectionl, Anti-inflammatory, Anti-allergy.

Geographically, the report provides an exhaustive analysis of geographical scenario of the market delivers detailed analysis including market size, share, year on year growth and opportunity analysis about the five major geographies including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Further, the regions are segmented into countries:
·        North America (U.S. & Canada)
·        Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
·        Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
·        Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
·        Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Some of major Ophthalmic Drugs market players are – Santen Pharmaceutical Co., Ltd., Bausch & Lomb Inc. (Valeant Pharmaceuticals International, Inc.), Shire Plc, Alcon (Novartis), Genentech, Inc., Allergan, Plc, Sun Pharmaceutical Industries Limited, Actavis Generics (Teva Pharmaceutical Industries Ltd.), Regeneron Pharmaceuticals, Inc., Pfizer Inc., among others.

This report provides detailed analysis of the company’s business and financial performance such as net revenue, sales split by segment and by region, SWOT Analysis, company overview, business strategy, product offerings, recent news & development and other major events. The report also analyzes company’s positioning and market share in Ophthalmic Drugs Market.
key features of the market research report include:
·        The report provides a basic overview of the market including its definition, market maturity analysis, porters five force analysis and value chain analysis
·        The report presents market dynamics which includes market drivers and restraints, industry trends, and market opportunities.
·        The report provides market size for 2017, preliminary estimate for 2017 and forecast for 2017-2023.
·        The total market is further divided and analyzed by geographies and countries
·        An all-inclusive data for segment market analysis by market segment on the basis of By Indication, By Type, By Dosage Form, By Technology, By Distribution Channel, By Therapeutic Class.
·        The report also offers market share of major players, and detailed company profile.


Table Of Content:

CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increase in focus of key players to develop combination therapies for the treatment of ophthalmic disorders
3.5.1.2. Rise in prevalence of ophthalmic disorders worldwide
3.5.1.3. Change in the demographics across the globe

3.5.2. Restraints

3.5.2.1. Longer timelines required for the development of ophthalmic drugs
3.5.2.2. Risk of side effects associated with ophthalmic drugs

3.5.3. Opportunity

3.5.3.1. Increase in investment by market players in the emerging economies

CHAPTER 4 OPHTHALMIC DRUGS MARKET, BY INDICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DRY EYE

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. GLAUCOMA

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. INFECTION/INFLAMMATION/ALLERGY

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. RETINAL DISORDERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Wet age-related macular degeneration

4.5.4.1. Market size and forecast

4.5.5. Dry age-related macular degeneration

4.5.5.1. Market size and forecast

4.5.6. Diabetic retinopathy

4.5.6.1. Market size and forecast

4.5.7. Others

4.5.7.1. Market size and forecast

4.6. OTHERS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

CHAPTER 5 OPHTHALMIC DRUGS MARKET, BY TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PRESCRIPTION DRUGS

5.2.1. Market size and forecast

5.3. OVER-THE-COUNTER DRUGS

5.3.1. Market size and forecast

CHAPTER 6 OPHTHALMIC DRUGS MARKET, BY DISTRIBUTION CHANNEL

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITAL PHARMACIES

6.2.1. Market size and forecast

6.3. DRUG STORES

6.3.1. Market size and forecast

6.4. ONLINE PHARMACIES

6.4.1. Market size and forecast

6.5. OTHERS

6.5.1. Market size and forecast

CHAPTER 7 OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. LIQUID OPHTHALMIC DRUG FORMS

7.2.1. Market size and forecast

7.3. SEMISOLID OPHTHALMIC DRUG FORMS

7.3.1. Market size and forecast

7.4. SOLID OPHTHALMIC DRUG FORMS

7.4.1. Market size and forecast

7.5. MULTICOMPARTMENT DRUG DELIVERY SYSTEMS

7.5.1. Market size and forecast

7.6. OTHER OPHTHALMIC DRUG FORMS

7.6.1. Market size and forecast
Continue:

Get Exclusive Discount on This Report:  https://www.kdmarketinsights.com/discount/5098

About Us:
KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Insights, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 300 companies and leading advisory firms.

Contact Us:
KD Market Insights
30 State Street, Albany,
New York, USA 12203
+1 (317) 300-1217





No comments:

Post a Comment